• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性和转移性胰腺腺癌中CD44异构体的表达

CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.

作者信息

Rall C J, Rustgi A K

机构信息

Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.

出版信息

Cancer Res. 1995 May 1;55(9):1831-5.

PMID:7537174
Abstract

CD44 is the transmembrane adhesion molecule which binds hyaluronate. The gene encoding CD44 is found on chromosome 11p and comprises 20 exons. Differential splicing of the 10 extracellular juxtamembranous exons (v1-10) generates the major isoforms of CD44. The major CD44 isoform found on hematopoetic cells (CD44s) contains none of the variably expressed exons, while the major isoform expressed on epithelial cells [CD44(v8-10)] contains exons v8-10. Metastasis-specific isoforms of CD44 were first documented in a model of rat pancreatic adenocarcinoma [CD44(v4-7), CD44(v6-7)] and subsequently in other cancers. This study is the first characterization of CD44 isoforms in primary and metastatic human pancreatic adenocarcinomas. CD44 isoforms were analyzed in specimens of 15 primary and 6 metastatic pancreatic adenocarcinomas as well as in 6 specimens of control pancreata by two different methods. Radiolabeled reverse transcriptase-PCR coupled with 8% PAGE allowed analysis of the major isoforms of CD44, while Southern blot hybridization with [alpha-32P]dCTP-labeled probes permitted analysis for metastasis-specific CD44 isoforms containing CD44(v6) or CD44(v8-10). No differences in the expression of CD44(v8-10) and CD44s were found among the primary and metastatic pancreatic adenocarcinomas, and control specimens of pancreata. However, a novel CD44(v6) isoform was found in metastatic lesions and may represent the human homologue of the rat pancreatic adenocarcinoma metastasis-associated CD44 isoform.

摘要

CD44是一种能结合透明质酸的跨膜黏附分子。编码CD44的基因位于11号染色体短臂上,由20个外显子组成。10个细胞外近膜外显子(v1 - 10)的可变剪接产生了CD44的主要异构体。造血细胞上发现的主要CD44异构体(CD44s)不包含任何可变表达的外显子,而上皮细胞上表达的主要异构体[CD44(v8 - 10)]包含外显子v8 - 10。CD44的转移特异性异构体最早在大鼠胰腺腺癌模型中被记录[CD44(v4 - 7),CD44(v6 - 7)],随后在其他癌症中也有发现。本研究首次对原发性和转移性人胰腺腺癌中的CD44异构体进行了特征描述。通过两种不同方法对15例原发性和6例转移性胰腺腺癌标本以及6例对照胰腺标本中的CD44异构体进行了分析。放射性标记的逆转录聚合酶链反应结合8%聚丙烯酰胺凝胶电泳可分析CD44的主要异构体,而用[α - 32P]dCTP标记的探针进行Southern印迹杂交可分析含有CD44(v6)或CD44(v8 - 10)的转移特异性CD44异构体。在原发性和转移性胰腺腺癌以及对照胰腺标本中,未发现CD44(v8 - 10)和CD44s表达的差异。然而,在转移灶中发现了一种新的CD44(v6)异构体,它可能代表大鼠胰腺腺癌转移相关CD44异构体的人类同源物。

相似文献

1
CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.原发性和转移性胰腺腺癌中CD44异构体的表达
Cancer Res. 1995 May 1;55(9):1831-5.
2
New CD44 splice variants associated with human breast cancers.与人类乳腺癌相关的新型CD44剪接变体。
J Cell Physiol. 1995 Jan;162(1):127-33. doi: 10.1002/jcp.1041620115.
3
Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.CD44的不同剪接变体在胃泌素瘤中表达,但在胰腺内分泌肿瘤的其他亚型中不表达。
Cancer Res. 1994 Feb 15;54(4):981-6.
4
Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.除了一些肿瘤外,正常人体组织表达多种不同的CD44同种型。
Cancer Res. 1994 Aug 15;54(16):4539-46.
5
Splice variants of CD44 in human cervical cancer stage IB to IIB.人类宫颈癌IB期至IIB期CD44的剪接变体
Gynecol Oncol. 1995 Jun;57(3):383-7. doi: 10.1006/gyno.1995.1159.
6
Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.透明质酸受体CD44和RHAMM在人胰腺癌细胞中的差异表达。
Clin Cancer Res. 1996 Sep;2(9):1607-18.
7
Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.人前列腺癌细胞中CD44变异体同工型与透明质酸及细胞骨架的相互作用
J Cell Physiol. 1995 Sep;164(3):605-12. doi: 10.1002/jcp.1041640319.
8
Alternative splicing of CD44 pre-mRNA in human colorectal tumors.人结肠直肠癌中CD44前体mRNA的可变剪接
Biochem Biophys Res Commun. 1994 Apr 29;200(2):1015-22. doi: 10.1006/bbrc.1994.1551.
9
Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.CD44在正常人体子宫内膜组织与肿瘤子宫内膜组织中的表达:CD44表达降低在癌细胞淋巴血管间隙浸润中的可能意义。
Cancer Res. 1994 Jul 15;54(14):3922-8.
10
CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.包含外显子V6和V7的CD44亚型在有丝分裂原刺激的正常和爱泼斯坦-巴尔病毒转化的人B细胞上差异表达。
Immunology. 1995 Sep;86(1):41-8.

引用本文的文献

1
CD44: a key regulator of iron metabolism, redox balance, and therapeutic resistance in cancer stem cells.CD44:癌症干细胞中铁代谢、氧化还原平衡及治疗抗性的关键调节因子。
Stem Cells. 2025 May 27;43(6). doi: 10.1093/stmcls/sxaf024.
2
Additional expression of T-cell engager in clinically tested oncolytic adeno-immunotherapy redirects tumor-infiltrated, irrelevant T cells against cancer cells to enhance antitumor immunity.在经临床测试的溶瘤腺免疫疗法中,T细胞衔接器的额外表达可将肿瘤浸润的无关T细胞重定向至癌细胞,以增强抗肿瘤免疫力。
J Immunother Cancer. 2024 Dec 9;12(12):e009741. doi: 10.1136/jitc-2024-009741.
3
Roles and mechanisms of aberrant alternative splicing in melanoma - implications for targeted therapy and immunotherapy resistance.
异常可变剪接在黑色素瘤中的作用和机制——对靶向治疗和免疫治疗耐药性的影响
Cancer Cell Int. 2024 Mar 10;24(1):101. doi: 10.1186/s12935-024-03280-x.
4
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential.胰腺导管腺癌中的剪接改变:具有转化潜力的新分子图谱。
J Exp Clin Cancer Res. 2023 Oct 26;42(1):282. doi: 10.1186/s13046-023-02858-z.
5
Cholesterol depletion decreases adhesion of non-small cell lung cancer cells to E-selectin.胆固醇耗竭降低非小细胞肺癌细胞与 E-选择素的黏附。
Am J Physiol Cell Physiol. 2023 Aug 1;325(2):C471-C482. doi: 10.1152/ajpcell.00197.2020. Epub 2023 Jul 3.
6
The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development.CD44 的 v8-10 变异体同工型在正常人类结肠干细胞龛中选择性表达,并且在肿瘤发展过程中在结肠癌中经常过表达。
Cancer Biol Ther. 2023 Dec 31;24(1):2195363. doi: 10.1080/15384047.2023.2195363.
7
Proteolysis of CD44 at the cell surface controls a downstream protease network.细胞表面CD44的蛋白水解作用控制着下游蛋白酶网络。
Front Mol Biosci. 2023 Feb 17;10:1026810. doi: 10.3389/fmolb.2023.1026810. eCollection 2023.
8
Genome-Wide Analysis of lncRNA-mRNA Co-Expression Networks in CD133+/CD44+ Stem-like PDAC Cells.CD133+/CD44+ 胰腺导管腺癌干细胞样细胞中lncRNA-mRNA共表达网络的全基因组分析
Cancers (Basel). 2023 Feb 7;15(4):1053. doi: 10.3390/cancers15041053.
9
Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands.唾液腺良性和恶性肿瘤中CD44s、CD44v6、CXCR2、CXCL1和IL-1β的评估
Diagnostics (Basel). 2022 May 20;12(5):1275. doi: 10.3390/diagnostics12051275.
10
CD44: A Multifunctional Mediator of Cancer Progression.CD44:癌症进展的多功能介质。
Biomolecules. 2021 Dec 9;11(12):1850. doi: 10.3390/biom11121850.